Page 24 - Pharma Industry

KKR-backed JB Chemicals scouts for acquisitions, plans to revamp business

With the former Cipla head at the helm, JB Chemicals now plans to diversify into paediatrics and respiratory

Pharmaceutical exports jumped 12.43% during April-December 2021

The exports grew to $17.57 billion, Parliament was informed on Friday

Jazz Pharma to buy GW Pharmaceuticals in a $7.2 billion cash-and-stock deal

GW Pharma's Epidiolex, the first marijuana-derived drug to be approved in the United States, generated sales of over $500 million for the U.K.-based company last year

PI Industries: Reaping gains from sustained growth across businesses

Strong beat in Q3, positive management commentary sees stock gain more than 9 per cent on Wednesday

Indegene's valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton

Given the wider adoption of digital initiatives within the healthcare industry, Indegene plans to use the funds to accelerate its M&A (merger and acquisition) and global expansion plans

Pharma to real estate, here's look at the winners and losers amid Covid-19

While several sectors like airlines and real estate are still reeling from the pandemic, here's is look at the winners and losers during the period

Sun Pharma Q3 PAT doubles to Rs 1,852 cr, rides on record quarterly revenue

The company has repaid debt of about $490 million in 9MFY21; filings for 90 ANDAs await US FDA approval

Eris Lifesciences Q3 net up 42% to Rs 90 cr, total income rises by 14%

Overall, the company saw decent growth in its product segments, led by cardio metabolic and vitamin-mineral-nutrients

Pharma industry has risen to occasion during the pandemic: Satish Reddy

He said the crisis itself presented the industry with several opportunities and allowed us to think differently

Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities

Govts or manufacturers, who is on the hook if Covid-19 vaccines go wrong?

Policy makers in developing nations may not have a choice but to take what they can get - easily, cheaply and quickly

Sun Pharma starts phase 2 trial for drug to treat plaque psoriasis

Sun Pharma on Monday said it has initiated Phase 2 clinical trial for a product being developed to treat patients with moderate to severe plaque psoriasis.

Gland Pharma's growth trajectory to remain elevated in medium term

Margin expansion to support profits, clean regulatory track record to help sustain growth journey

Phase 3 trial of Novavax investigational coronavirus vaccine begins

The Phase 3 trial of another investigational Covid-19 vaccine developed by biotechnology company Novavax, has started enrolling adult volunteers, the US National Institutes of Health (NIH) announced

India to play key role in vaccine rollout around the world: Pharma industry

The world is looking at India as a beacon of hope to manufacture and supply the huge number of vaccines needed to tackle the pandemic

Scientists find new class of drugs that may treat blood, bone marrow cancer

A group of scientists in the US, including an Indian-American from the prestigious Cleveland Clinic, have identified a potential new class of drugs that may prove effective in treating certain common types of blood and bone marrow cancers. First published in the latest edition of Blood Cancer Discovery, the decade long research which reports that a new pharmacological strategy to preferentially target and eliminate leukemia cells with TET2 mutations, was carried out by Jaroslaw Maciejewski and his collaborator Babal Kant Jha from the Cleveland Clinic Department of Translational Hematology & Oncology Research. Myeloid leukemias are cancers derived from stem and progenitor cells in the bone marrow that give rise to all normal blood cells. One of the most common mutations involved in driving myeloid leukemias are found in the TET2 gene, which has been investigated for the last decade by Maciejewski and Jha. In preclinical models, we found that a synthetic molecule called TETi76 was ..

Dr Reddy's seeks nod from Canada for Favipiravir pills for Covid treatment

Dr Reddy's Canada has filed an application on behalf of the consortium for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate Covid-19 adult patients

Glenmark Pharma gets tentative nod from USFDA for blood thinning drug

Drug major Glenmark Pharma on Monday said it has received tentative approval from the US health regulator for anticoagulant Dabigatran Etexilate capsules

Making markets work for affordable medicines

Regulatory safeguards to ensure quality and efficacy of drugs are a necessary pre-condition for effective competition between generic and branded drugs

Aurobindo Pharma gets USFDA approval for drug used to sedate patients

Drug major Aurobindo Pharma said it has received final approval from the US health regulator for generic of Precedex injection, used for sedation of patients